Startup Funding Stages: Pre-Seed to Series D Explained

Every startup funding stage explained: pre-seed, seed, Series A, B, C and D, with typical raise size, valuation, dilution and who invests at each.

Funding StagesPre-seedSeedSeries ASeries BFundraisingRound Funded
Amara Okafor
Amara OkaforFundraising Writer
Round Funded logo

Round Funded

Search 60,000+ verified investors and reach them directly. Start raising today.

Start Raising

Startup Funding Stages in 2026: The Complete Map

Startup funding moves through named stages in a fixed order: pre-seed, seed, Series A, Series B, Series C, and Series D, plus later lettered rounds for companies that need one more round before an IPO or acquisition. Each stage carries its own typical check size, valuation range, dilution, and investor type. This guide maps every stage with 2026 medians from Carta and PitchBook-NVCA: what it funds, who writes the check, and what has to be true before you raise it, so you can build a stage-matched list on Round Funded instead of guessing.

The stage names matter because investors specialize by stage. A Series B fund does not read pre-seed decks, and a pre-seed angel does not write an $8M check. Match the stage to your evidence first, then match the sector.


The Startup Funding Stage Comparison Table

The ranges below are anchored on the two datasets that publish stage-by-stage medians for US venture rounds: the PitchBook-NVCA Venture Monitor for Q2 2026 (deals through June 30, 2026) and Carta's Q2 2026 Round Benchmarking medians, published in Carta's Series A guide, plus Carta's 1,000-round software benchmarks for rounds closed in the six months to July 2026. Treat every figure as a working range, not an appraisal; AI-native companies in particular skew the top end. Carta's 2025 in review puts the median AI Series A valuation 38 percent above non-AI, and its Q1 2026 data shows more than 60 percent of venture dollars going to AI companies (Carta Series A guide).

StageTypical raiseTypical valuationTypical dilutionWho investsWhat must be true
Pre-seed$250K - $1M$8M pre-money to $10M SAFE capRaise divided by cap, about 2.5% - 10%Angels, pre-seed funds, acceleratorsTeam + working prototype
Seed$3M - $4.5M$18M pre-money to $24M post-moneyAbout 18% - 19%Seed VCs, larger angels, micro fundsEarly revenue or usage with retention
Series A$14M - $19M$55M - $80M post-moneyAbout 18% - 19%Institutional VCs, one leadRepeatable growth engine
Series B$23M - $40M$165M - $191M post-moneyAbout 12% - 13%Growth VCs, crossover fundsScalable unit economics
Series C$40M - $75M$390M post-money to $546M pre-moneyUnder 10%Late-stage VCs, private equityCategory leadership
Series D+$63M - $150M+$790M+ post-moneyAbout 8%Crossover funds, PE, pre-IPO investorsPath to IPO or exit

Where each row comes from, with the period stated:

  • Pre-seed: the PitchBook-NVCA Venture Monitor for full-year 2025 reports a $0.5M median pre-seed deal and an $8.3M median pre-money on deals with a reported valuation, the row's floor. Carta's State of Pre-Seed 2025 buckets SAFE rounds as $250K to $1M and $1M to $2.5M, with median post-money caps of about $10M and $15M respectively for full-year 2025. Dilution on a SAFE is raise divided by cap.
  • Seed: Carta's Q2 2026 medians are $4.5M on a $23.9M post-money, 19.4 percent dilution (Carta Series A guide); its software benchmarks show $4.1M on $24.3M post-money, 18 percent sold (Carta benchmarks). PitchBook-NVCA puts the H1 2026 median seed deal at $3.0M (Q2 2026 Venture Monitor) and the Q1 2026 median seed pre-money at $18.4M, the row's floor (Q1 2026 Venture Monitor).
  • Series A: Carta's Q2 2026 medians are $14.7M on a $76.3M post-money, 18.7 percent dilution, and its Q1 2026 data puts a comparable non-AI Series A at roughly $55M, the row's floor (Carta Series A guide); its software benchmarks show $14.4M on $80M post-money, 18 percent sold (Carta benchmarks). PitchBook-NVCA reports an H1 2026 median Series A deal of $19.4M on a $64.0M median pre-money (Q2 2026 Venture Monitor).
  • Series B: Carta's Q2 2026 medians are $23.3M on a $166.2M post-money, 13.4 percent dilution, the row's floor (Carta Series A guide); its software benchmarks show $25M on $191M post-money, 12 percent sold (Carta benchmarks). PitchBook-NVCA reports an H1 2026 median Series B deal of $40.0M on a $188.3M median pre-money (Q2 2026 Venture Monitor), with Q1 2026 at $203.0M (Q1 2026 Venture Monitor).
  • Series C: PitchBook-NVCA reports an H1 2026 median Series C deal of $74.0M on a $546.0M median pre-money (Q2 2026 Venture Monitor). Carta's software benchmarks show roughly $40M on a $391M post-money, less than 10 percent sold (Carta benchmarks).
  • Series D+: Carta's software benchmarks show a $63M median Series D on a $789M post-money, 8 percent sold (Carta benchmarks). PitchBook-NVCA reports an H1 2026 median Series D+ deal of $150.0M on a $2,031.4M median pre-money (Q2 2026 Venture Monitor).

One structural note: most pre-seed and many seed rounds close on SAFEs (simple agreements for future equity), not priced equity. Per Carta's SAFE valuation caps report for Q2 2026, 93 percent of pre-seed rounds closed on SAFEs in Q2 2026, 91 percent of those were post-money, and 94 percent of post-money SAFEs carried a cap in the first half of 2026.


Pre-Seed to Series D: Each Funding Stage Explained

Each stage below covers the raise, valuation, investor expectations, instrument, and the mistake that most often kills the round.

Pre-Seed Funding: The Team and Prototype Round

Pre-seed money funds a team and a working prototype, not a business. It typically raises $250K to $1M on a SAFE capped at about $10M for rounds up to $1M and about $15M for $1M to $2.5M rounds (Carta, full-year 2025, sourced in the table above). The round is assembled from many small checks rather than one lead.

What investors expect: founder-market fit (why you win this problem), something shipped and live even if rough, and a signal of pull such as a waitlist, a few paying users, or a pilot letter of intent. In 2026, with AI tooling collapsing build costs, "we have not built anything yet" reads as a red flag.

Instrument: almost always a post-money SAFE, occasionally a convertible note; SAFEs over $2.5M carried a $35M median cap in Q2 2026 per Carta's SAFE report. Accelerators write pre-seed-sized checks too: Y Combinator's standard deal is $500,000, split into $125,000 for a fixed 7 percent and $375,000 on an uncapped MFN (Most Favored Nation) SAFE, per ycombinator.com/deal.

What goes wrong: founders raise too much too early, selling 20 percent or more on a cheap cap before they have the evidence, roughly double what Carta's medians imply ($1M on a $10M cap sells 10 percent), or they pitch a seed-stage story nobody can verify yet. Match the ask to the milestone, not the ambition, and start with pre-seed angel investors actively writing first checks.

Seed Funding: The Traction Round

Seed funding is where the questions turn quantitative. It typically raises $3M to $4.5M at roughly $18M pre-money to $24M post-money (Carta and PitchBook-NVCA medians, sourced in the table above). The bar sits higher than it did five years ago because AI collapsed the cost of building something that looks finished.

What investors expect: revenue or usage that retains, not just exists. For B2B SaaS, early MRR with cohorts that flatten instead of decaying gets meetings; for consumer, retention curves matter more than download counts. A visible month-over-month climb beats a flat number with a good story.

Instrument: SAFEs remain common at seed, though a lead fund that wants board rights will price the round. Unlike pre-seed, a seed round usually has a lead investor who sets terms and takes a board or observer seat. Expect to sell about a fifth of the company: median seed dilution was 19.4 percent in Q2 2026 (Carta).

What goes wrong: founders pitch seed funds on pre-seed evidence (a prototype and a hope) and burn their best targets on a pass. The other failure is spending months hunting a lead before testing the market at all: run outreach to seed funds and larger angels in parallel, not in sequence.

Series A: The First Priced Round

Series A is institutional money and, for most companies, the first fully priced round with a real board seat attached. It typically raises $14M to $19M at roughly a $55M to $80M post-money valuation (sourced in the table above). AI skews the top of that range: Carta's Q1 2026 data shows a foundational-model Series A near a $300M median valuation versus roughly $55M for a comparable non-AI startup (Carta Series A guide). The question changes from "does anyone want this" to "does this grow predictably when you feed it money."

What investors expect: a repeatable growth engine, meaning revenue growing fast and retaining, with cohorts flat or expanding rather than leaking. Go-to-market efficiency matters almost as much as the topline; investors read how you got there, not only where you landed.

Instrument: a priced equity round, negotiated with a term sheet, a lead investor, and a board seat. Median Series A dilution was 18.7 percent in Q2 2026 (Carta). Run your dilution scenarios before you are in a live negotiation.

What goes wrong: a sloppy back office can kill a Series A as surely as a weak pitch. Diligence now includes cohort data and customer reference calls before the term sheet, not after. Read the full process in our how to raise a Series A guide.

Series B: Proving the Growth Engine Scales

Series B funds the machine that turns product-market fit into predictable growth at a larger scale. It typically raises $23M to $40M at roughly a $165M to $191M post-money valuation (sourced in the table above).

What investors expect: proof that acquisition and sales efficiency hold up as spend rises. Growth VCs and crossover funds dig into CAC payback, cohort economics by channel, and whether the go-to-market motion works once it is not founder-led.

Instrument: a priced round, typically with a new lead plus the Series A investors following on to defend their ownership. Dilution is lower than at seed or Series A: 13.4 percent median in Q2 2026 (Carta).

What goes wrong: founders scale spend faster than the unit economics can absorb, chasing growth-at-any-cost numbers that look great in a deck and terrible in a cohort table. Series B investors have seen that story before and diligence specifically for it.

Series C: Category Leadership

Series C funds expansion once the core business is proven: new geographies, new product lines, or acquisitions that consolidate a category. It typically raises $40M to $75M at roughly a $390M post-money (Carta) to $546M pre-money (PitchBook) valuation (sourced in the table above), up sharply from PitchBook-NVCA's full-year 2025 medians of a $54.0M deal on a $316.3M pre-money (FY2025 Venture Monitor).

What investors expect: evidence of category leadership, not just growth, meaning multiple product lines or markets working at once, management depth beyond the founders, and a credible path toward the metrics public investors will price.

Instrument: a priced round, often the first with meaningful private equity or sovereign fund participation, selling less than 10 percent of the company on Carta's software data.

What goes wrong: companies raise a Series C to paper over a growth slowdown instead of funding genuine expansion. Investors at this stage have the diligence resources to tell the difference, and a down or flat round signals trouble that is hard to walk back publicly.

Series D and Later: Pre-IPO or One More Round

Series D and beyond typically raise $63M to $150M or more at roughly a $790M-plus post-money valuation (sourced in the table above). The round tells one of two stories: a genuine pre-IPO round priced against public-market comparables, or a company that needed one more round than planned.

What investors expect: metrics that would survive a public-market read: durable growth, a clear path to profitability or an already-profitable core, and public-company-grade governance. Crossover funds and pre-IPO investors dominate this stage.

Instrument: a priced round, frequently structured with downside protections such as liquidation preferences or ratchets that earlier stages rarely need.

What goes wrong: the "one more round" story, told quietly, can mask a company that has stopped compounding. A Series D that funds real expansion is a healthy company; one that funds a slowdown is buying time.


Where Round Funded Fits

Round Funded runs on one idea: stage mismatch is the most avoidable fundraising mistake, and pitching a Series B fund at pre-seed wastes the founder's time and the investor's.

Round Funded is a database of 60,000+ active investors, filterable by the exact stage, sector, and geography you are raising at, so every list you build is stage-matched before you send a single email. Outreach runs from your own Gmail with AI-drafted, personalized messages, and every founder gets a free Data Room to share real traction data.

Browse 60,000+ stage-matched investors on Round Funded →


How to Raise Your Current Round: Step by Step

  1. Build a stage-matched list on Round Funded. Filter the investor database by your exact stage, sector, and geography before you send a single message.
  2. Nail your stage's proof point. Team and prototype at pre-seed, revenue and retention at seed, a repeatable growth engine at Series A and beyond. Do not pitch the next stage's story without this stage's evidence.
  3. Pick the right instrument. SAFEs at pre-seed and often seed, a priced round from Series A onward. Model the SAFE conversion and the dilution stack before you sign anything.
  4. Size the ask to at least 24 months of runway. Carta's data argues the old 18-to-24-month rule is a floor, not a target: the median gap from seed to Series A reached 616 days in Q2 2025 (Carta). Raise enough to hit the next stage's milestones with a buffer for the raise itself.
  5. Run outreach in batches, not a single blast. Send a consistent weekly volume, track replies, and refine the target list as patterns emerge.
  6. Create momentum, then a close date. Investors move when other investors move. Batch meetings into a short window so term sheets land close together.
  7. Close and get back to work. A round is fuel, not a finish line. Budget your attention for the next stage's evidence the day this one closes.

Frequently Asked Questions

What is Series A funding?

Series A is a startup's first fully priced venture round, typically $14M to $19M at roughly a $55M to $80M post-money valuation, led by one investor who sets the price and takes a board seat. Carta's Q2 2026 median is $14.7M on a $76.3M post-money (Carta). Build your target list from active Series A VCs.

How much is a Series A?

The 2026 median Series A is $14.7M on Carta's Q2 2026 data (Carta) and $19.4M on PitchBook-NVCA's H1 2026 data (Venture Monitor). AI companies raise well above that: Carta's Q1 2026 data puts a foundational-model Series A near a $300M median valuation. Treat any single figure as a reference, not a target.

What is the difference between pre-seed and seed funding?

Pre-seed funds a team and a working prototype, usually $250K to $1M from angels and accelerators. Seed funds early traction, usually $3M to $4.5M led by a seed fund. The dividing line is evidence: seed investors expect revenue or retention data a stranger would believe, pre-seed investors do not.

What is the difference between Series A and Series B?

Series A proves a growth engine exists at a small scale, typically $14M to $19M with one lead pricing the round for the first time. Series B proves that same engine scales, typically $23M to $40M, with growth VCs digging into CAC payback and channel-level unit economics rather than the topline growth number alone.

What comes after Series C?

Series D, then further lettered rounds if needed, usually followed by an IPO or acquisition. Series D and later rounds typically raise $63M to $150M or more at roughly a $790M-plus post-money valuation, priced either for public markets or to fund one more stretch of growth. Crossover funds and private equity are the usual investors.

What order do startup funding stages go in?

Pre-seed, seed, Series A, Series B, Series C, then Series D and later rounds, ending in an IPO or acquisition. Each stage raises more capital at a higher valuation and a harder proof bar than the one before it, from a prototype at pre-seed to a repeatable growth engine at Series A.

How much equity do you give up at each funding stage?

Median dilution runs about 19 percent at seed, 19 percent at Series A and 13 percent at Series B (Q2 2026, per Carta), then under 10 percent at Series C and about 8 percent at Series D (software rounds to July 2026, per Carta benchmarks). Pre-seed is raise divided by SAFE cap. Model the compounding with the cap table calculator.

How long does it take to get from seed to Series A?

Longer than most plans assume: the median gap between a seed round and a Series A was 616 days, about 20 months, for companies that raised their A in Q2 2025, per Carta. Budget seed money for two years of milestones, not one, and start the Series A process with six months of runway left.


Know Your Stage, Then Raise Like You Mean It

Funding stages are not bureaucracy; they are a shared language that tells you exactly what to prove and who to call. Get the stage right, build the evidence, and run outreach with volume and discipline.

Start raising from 60,000+ stage-matched investors →


Stop guessing which investors fit your round. Find your stage on Round Funded.

Round Funded logo

Round Funded

Search 60,000+ verified investors and reach them directly. Start raising today.

Start Raising